Stock listing
Arovella Therapeutics Limited
Selected listing: A3C575 · LSX · EUR · DE
Arovella Therapeutics Limited (LS Exchange: A3C575), Health Technology. Latest release Oct 6, 2026: Second Clinical Batch Released for Immediate Patient Use.
- Ticker
- LS Exchange: A3C575
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- LS Exchange
- Currency
- EUR
About Arovella Therapeutics Limited
The company is focused on developing innovative therapies in the biotechnology sector. Arovella aims to address unmet medical needs through its research and development efforts.
Latest news from Arovella Therapeutics Limited
Research Arovella Therapeutics Limited
Arovella Therapeutics Limited company profile
View the public company page for Arovella Therapeutics Limited on 6ix.
Arovella Therapeutics Limited news
Read company news and market updates connected to Arovella Therapeutics Limited.
Arovella Therapeutics Limited investor events
Find investor webinars, events, and replay context for Arovella Therapeutics Limited.
Alternate listings
ALA:ASX
AU · AUD
Alternate listing for Arovella Therapeutics Limited; the primary context on this page is A3C575:LSX.
A3C575:LS
DE · EUR
Alternate listing for Arovella Therapeutics Limited; the primary context on this page is A3C575:LSX.
E4NA:DUS
DE · EUR
Alternate listing for Arovella Therapeutics Limited; the primary context on this page is A3C575:LSX.
E4NA:FWB
DE · EUR
Alternate listing for Arovella Therapeutics Limited; the primary context on this page is A3C575:LSX.
E4NA:SWB
DE · EUR
Alternate listing for Arovella Therapeutics Limited; the primary context on this page is A3C575:LSX.